Dr. Samuel Adam Geurkink, DO Internal Medicine - Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 9750 Hillwood Pkwy, Ft Worth, TX 76177 Phone: 817-697-5620 Fax: 817-379-2024 |
News Archive
The New York State Department of Health in the next few weeks is expected to issue a final decision on whether to switch Medicaid beneficiaries with HIV/AIDS from fee-for-service plans to managed care plans, the AP/Long Island Newsday reports (AP/Long Island Newsday, 8/24).
Navidea Biopharmaceuticals, Inc., a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, today announced it has entered into an agreement to collaborate with Maimonides Medical Center to investigate the utility of Lymphoseek (technetium Tc 99m tilmanocept) Injection in lymphatic mapping procedures for colorectal cancer.
Researchers in the United States have made an important discovery about the processing and presentation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral peptides that provides a better understanding of the immune response to coronavirus disease 2019 (COVID-19) and may help facilitate the design of improved vaccines.
Researchers have determined that two Phase 1 drugs (CX-4945 and JQ1) can work together to efficiently kill T-cell acute lymphoblastic leukemia cells while having minimal impact on normal blood cells.
In a study to be presented on Feb. 6 at 3 p.m. CST, at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting-, in New Orleans, researchers will report that women ages 35 and older are at a decreased risk of having a child with a major congenital malformation, after excluding chromosomal abnormalities.
› Verified 6 days ago